版本:
中国

BRIEF-3D signatures plans to announce clinical trial for Hodgkin's Lymphoma precision medicine test in coming months

Oct 17 3d Signatures Inc :

* 3DS plans to announce a clinical trial for a Hodgkin's Lymphoma precision medicine test in coming months

* Expects to engage laboratory partner in validation, approval of a Hodgkin's Lymphoma Laboratory Developed Test (LDT) for Canada in 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐